INTRODUCTION
Micronuclei (MN) originate from chromosome fragments or whole chromosomes that fail to engage with the mitotic spindle during cell division. The cytokinesis-block micronucleus (CBMN) assay in human lymphocytes is a widely used technique for measuring DNA damage in human population (FENECH, 2010) . In general, the frequency of MN appears to be mainly modulated by endogenous factors, such as the age and gender and by lifestyle factors, such as smoking, alcohol drinking, nutritional factors (BONASSI et al., 2001; KAZIMIROVA et al., 2006; GARAJ-VRHOVAC et al., 2008) .
Disease (cancer, coronary artery disease), occupational and environmental exposure to genotoxics agents, as well as therapeutic treatments can affect MN frequency in human lymphocytes (HESSEL et al., 2001; MIGLIORE et al., 2011) .
The aim of this study was to explain inter-individual variability of induced MN frequency in PBLs of patients after application of the same doses of medicaments, taking into account factors that may influence the MN frequency, such as baseline MN frequency, age, smoking and occupational exposure.
MATERIALS AND METHODS

Patients
The study included 32 phenotypically healthy pregnant women in mid-trimester with a diagnosed uterine cervical insufficiency and threatening spontaneous abortions, observed at the Department of Obstetrics and Gynaecology in Kragujevac, Serbia. After the intervention, all patients received the same dose of tocolytic ritodrine, antiarrhythmic verapamil and antibiotic erythromycin for six days. This study was approved by the Ethics Committee of the Clinic Centre Kragujevac (01-4886). The mean age of the patients was 28.13 ± 5.17 years. All patients completed a questionnaire including personal data, working activity, environmental and occupational exposure to genotoxic agents and smoking habits. Out of 32 patients, 9 were occupationally exposed to different agents (locksmiths, doctors, a pharmacist, hairdressers). Other patients were not exposed to environmental and occupational mutagens. Sixteen patients were smokers (≈ 5-10 cigarettes/day).
Micronucleus test (MNT)
In our cytogenetic investigation, the cytokinesis block micronucleus (CBMN) test described by FENECH and MORLEY (1985) was used. Whole heparinized blood (0.5 mL) was added into 5 mL of PBMax Karyotyping (Invitrogen, California, USA), the complete medium for lymphocyte cultivation. Cell cultures were incubated at 37°C for 72 hours. After forty-four hours of incubation, Cytochalasin B (Sigma, St. Louis, MO, USA) was added to cultures in the final concentration of 4 µg/mL. The cultures were harvested for 28 hours. Then, the cells were treated with cold hypotonic solution (0.5% KCl) for 5 min and fixed with a fixative (methanol: glacial acetic acid = 3:1) three times. The slides were dried in air and stained with 2% Giemsa (Alfapanon, Novi Sad, Serbia) for 10 minutes.
Baseline and induced MN frequencies were determined by the analysis of 1000 binucleated cells (BN) per subject, according to the criteria described by FENECH (2000) .
Statistical analysis
The results were shown as mean ± standard deviation (SD). Statistically significant difference between the mean baseline and induced MN frequencies was determined using the Student's t-test. The level of significance was p < 0.05; p < 0.001. The inter-individual variance in baseline and induced MN frequency in BN cells was determined by the analysis of variance (ANOVA), which compared professionally exposed patients to the non-exposed.
Multivarate logistic regression was performed to calculate odds ratios (ORs) and 95% confidence intervals (CIs), and to assess the impact of independent variables (age, smoking status, baseline MN frequency) on the dependent variable (induced MN frequency). For the examination of marker quality, a receiver operating characteristic (ROC) curve analysis was performed to assess the potential of MN frequencies to discriminate the difference between before and after the therapy. Sensitivity and specificity were calculated at all possible cut-off points to find the optimal cut-off value.
RESULTS
The individual response to the baseline and induced MN frequency in the PBLs of the patientis with a diagnosed cervical insufficiency are presented in Table 1 . The individual baseline variation of MN frequency varied from 2 to 16 MN/1000 BN cells. The induced individual frequency of MN varied from 4 to 21 MN/1000 BN cells. Table 1 shows summarized results of the MN frequency in the lymphocytes of patients, before and after the therapy with relation to age, smoking status, professional exposure and professional occupations. In the patients professionally exposed to mutagenic agents, the mean baseline and induced MN frequency were increased in comparison to the baseline and induced MN frequency in the non-professionally exposed (p < 0.001; p < 0.05).
ANOVA for baseline and induced MN frequency shows statistically significant differences in the comparison between group (S 2 BG ) and within group (S 2 WG ) variances (F = 13.45; p < 0.05 for baseline MN frequency, and F = 8.25; p < 0.001 for induced MN frequency), when professionally exposed patients were compared to the non-exposed.
The detection of patients with induced MN frequency ≥ 12 MN/1000 BN cells is presented in Graph 1 using receiver operating characteristics (ROC) curve. The area under the ROC curve (95% CI) was 0.937 (0.857 -1.017, p < 0.001). Optimally cut-off value of baseline MN frequency is less than 8.5 MN/1000 BN cells. Multivariate logistic regression analysis confirmed that patients with high baseline MN frequency (>8.5 MN/1000 BN) had significantly increased induced MN frequency (>12 MN/1000 BN cells), (OR = 5.875; CI = 1.28-26.795, p < 0.05), with the sensitivity of 80%, and specificity of 94.2%. (LONČAR et al., 2004; ANDREASSI et al., 2005) reported similar results about the variability of baseline MN values, which could be affected by different factors (lifestyle, various medical therapies and climatic changes), or provide an index of accumulated genetic damage occurring during the life span of these cells. The comparison of baseline MN frequencies between professionally exposed patients and the non-exposed ones showed a statistically significant difference. These findings may be explained as the response of patients' lymphocytes to environmental mutagens.
Among the lymphocytes of patients after the therapy, the individual variation in MN/1000 BN cells ranged from from 4 to 21. The variability in the induced MN frequency can be explained as a different individual reactivity of human lymphocytes to the applied therapy. Previous investigations showed that in different persons treated by the same dose of mutagen, the level of chromosomal aberrations was different, which was explained by individual reactivity (SARITHA and AHUJA, 1990; MILOŠEVIĆ-DJORDJEVIĆ et al., 1996) .
ANOVA showed statistically significant difference between-group vs. within-group variance in baseline (p < 0.05) and induced MN frequency (p < 0.001), in professionally exposed patients when compared to the non-exposed. Our results showed greater inter-individual variation in baseline MN frequency which could be explaned by difference in PBL reactivity. On the other hand, ANOVA showed that induced MN frequency could be atrributed to individual reactivity to the therapeutic tretament.
Most of the patients who had lower baseline MN frequencies also had lower induced MN frequencies, which could be explained by their individual susceptibility. The results of multivariate logistic regression analysis confirmed that patients with high baseline MN frequency (cut-off 8.5 MN/1000 MN) had significant increase of induced MN frequency (>12 MN/1000 BN cells).
Based on our results, it can be concluded that the baseline MN frequency in PBLs has directly influenced the scope of induced MN response. Higher baseline MN frequency contributed to higher reactivity of PBLs, which can be the explanation for the inter-individual variability in MN response. Izvod Cilj ovog rada je objasniti interindividualnu varijansu u bazalnoj i indukovanoj frekvenci mikronukleusa (MN) u limfocitima periferne krvi pacijentkinja sa insuficijencijom cerviksa uterusa. Bazalni i indukovani MN odgovor u limfocitima periferne krvi 32 pacijentkinje je utvrđivan pomoću citokinezis-blok mikronukleus (CBMN) metode. Utvrđena prosečna vrednost indukovane MN frekvence (11.31 ± 4.44/1000 BN ćelija) je značajno viša (p < 0.001) u poređenju sa njihovom bazalnom frekvencom (7.81 ± 3.33 MN/1000 BN). Analiza varijanse (ANOVA) je pokazala statistički značajnu razliku između međugrupne u odnosu na unutargrupnu varijansu u bazalnoj (p < 0.05) i indukovanoj MN frekvenci (p < 0.001), kod profesionalno eksponiranih pacijentkinja u poređenju sa ne eksponiranim. Multivarijantna logistička regresiona analiza pokazuje da su pacijentkinje sa višom bazalnom MN frekvencom (cut-off 8.5 MN/1000 MN), imale značajno povećanu (odds ratio OR = 5.875; CI = 1.28 -26.795, p < 0.05) indukovanu MN frekvencu (>12 MN/1000 BN). Ovi rezultati sugerišu da bazalna MN frekvenca u limfocitima periferne krvi direktno utiče na obim indukovanog MN odgovora.
ACKNOWLEDGEMENT
